S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Apollo Medical Stock Forecast, Price & News

+0.02 (+0.05%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
262,889 shs
Average Volume
323,243 shs
Market Capitalization
$2.16 billion
P/E Ratio
Dividend Yield
Price Target

Apollo Medical Stock Forecast (MarketRank)

Analyst Rating
Moderate Buy
2.50 Rating Score
138.3% Upside
$92.00 Price Target
Short Interest
19.39% of Float Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
Insider Trading
Selling Shares
$9.25 M Sold Last Quarter
Proj. Earnings Growth

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.51 out of 5 stars

Medical Sector

569th out of 1,429 stocks

Management Consulting Services Industry

15th out of 27 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

Apollo Medical logo

About Apollo Medical (NASDAQ:AMEH)

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

AMEH Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Management consulting services
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
2 Analysts


Net Income
$73.86 million
Pretax Margin


Sales & Book Value

Annual Sales
$773.91 million
Cash Flow
$1.60 per share
Book Value
$8.29 per share


Free Float
Market Cap
$2.16 billion
Not Optionable

Apollo Medical Frequently Asked Questions

Should I buy or sell Apollo Medical stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Apollo Medical stock.
View analyst ratings for Apollo Medical
or view top-rated stocks.

What is Apollo Medical's stock price forecast for 2022?

2 Wall Street research analysts have issued 1 year target prices for Apollo Medical's stock. Their AMEH stock forecasts range from $92.00 to $92.00. On average, they expect Apollo Medical's stock price to reach $92.00 in the next twelve months. This suggests a possible upside of 138.3% from the stock's current price.
View analysts' price targets for Apollo Medical
or view top-rated stocks among Wall Street analysts.

How has Apollo Medical's stock price performed in 2022?

Apollo Medical's stock was trading at $73.48 at the beginning of the year. Since then, AMEH stock has decreased by 47.5% and is now trading at $38.61.
View the best growth stocks for 2022 here

When is Apollo Medical's next earnings date?

Apollo Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Apollo Medical

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) posted its quarterly earnings data on Thursday, May, 5th. The company reported $0.31 earnings per share for the quarter. The firm earned $263.26 million during the quarter. Apollo Medical had a net margin of 8.71% and a trailing twelve-month return on equity of 16.80%.
View Apollo Medical's earnings history

What guidance has Apollo Medical issued on next quarter's earnings?

Apollo Medical updated its FY 2022 earnings guidance on Monday, May, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.05 billion-$1.08 billion, compared to the consensus revenue estimate of $1.05 billion.

Who are Apollo Medical's key executives?

Apollo Medical's management team includes the following people:
  • Dr. Kenneth T. Sim M.D., Exec. Chairman (Age 68, Pay $1.09M)
  • Dr. Thomas S. Lam M.D., M.P.H., Pres, Co-CEO & Director (Age 73, Pay $1.08M)
  • Mr. Brandon Sim, Co-Chief Exec. Officer (Age 28, Pay $1.04M) (LinkedIn Profile)
  • Dr. WaiChow Young M.D., Chief Admin. Officer (Age 75, Pay $453.73k)
  • Mr. Chan Basho, Chief Strategy Officer & Interim CFO
  • Dr. Jeremy R. Jackson M.D., Chief Quality Officer
  • Mr. Neil Ahuja, Pres of Provider Solutions
  • Yubin Park, Chief Analytics Officer

What is Thomas Lam's approval rating as Apollo Medical's CEO?

9 employees have rated Apollo Medical CEO Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among Apollo Medical's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Square (SQ) and Exxon Mobil (XOM).

What is Apollo Medical's stock symbol?

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

How do I buy shares of Apollo Medical?

Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apollo Medical's stock price today?

One share of AMEH stock can currently be purchased for approximately $38.61.

How much money does Apollo Medical make?

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $2.16 billion and generates $773.91 million in revenue each year. The company earns $73.86 million in net income (profit) each year or $1.629990 on an earnings per share basis.

How many employees does Apollo Medical have?

Apollo Medical employs 1,133 workers across the globe.

How can I contact Apollo Medical?

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for Apollo Medical is www.apollomed.net. The company can be reached via phone at (626) 943-6491, via email at [email protected], or via fax at 818-839-5190.

This page (NASDAQ:AMEH) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.